Weed on wheels: Medex lights up London with Adverttu on-car advertising

Adverttu, the AdTech company, has launched its latest on-car advertising campaign with global pharmaceutical distributor, Medex and its ecommerce partner KAAM. For 8 weeks, Medex’s CBD 16mg patch product will adorn a fleet of Adverttu ad wrapped vehicles across Central and South West London.

Sunny Patel, Operations Manager at KAAM, said: “Hemp and cannabis-based product sales in the health and wellbeing sector are growing tremendously; market competitiveness increases every day. Our innovative patch technology deserves innovative advertising, which brought us to Adverttu. Its on-car advertising platform means we can target our audience hyper-locally and gain the benefits from eye catching, roving advertising that delivers high-impact, ubiquitous reach into the urban environment. Everything is automated, which makes campaign management a rewarding experience.”

With Adverttu, brands can easily advertise ‘on the road.’ Using Adverttu’s campaign simulation capabilities, Medex and KAAM can assess expected performance, coverage and spend before drivers hit the roads.

Equipped with accurate £CPM, reach and attribution data throughout the campaign, Medex and KAAM can ensure measurable impressions reach for both pedestrian and motoring traffic audiences, thereby increasing return on investment, targeting effectiveness and delivering hyper-localised brand exposure.

Artjom Jekimtsev, CEO and founder of Adverttu said: “Advertising with Adverttu is already more memorable than other out of home advertising formats, however few symbols turn heads as quickly as the iconic green cannabis leaf. Emblazoned on our drivers’ white, silver and black cars, colours easily selected by Medex using our intuitive platform, these head turning visuals will send the company’s impact and brand recall rates sky high. This could well be the most visually striking campaign of 2020!”

KAAM CBD patches are manufactured in the UK using organic, natural ingredients. The product is 100% legal, undergoes extensive laboratory testing procedures, and complies with all necessary safety, legal and quality requirements. 

Comments (0)

Add a Comment

This thread has been closed from taking new comments.

Editorial: +44 (0)1892 536363
Publisher: +44 (0)208 440 0372
Subscribe FREE to the weekly E-newsletter